Westfield Capital Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-888,247
Closed -$21.8M 280
2015
Q3
$21.8M Sell
888,247
-555,200
-38% -$15.7M 0.15% 170
2015
Q2
$33.8M Sell
1,443,447
-249,003
-15% -$5.42M 0.21% 133
2015
Q1
$38M Sell
1,692,450
-4,310
-0.3% -$82.6K 0.22% 134
2014
Q4
$28.6M Sell
1,696,760
-70,744
-4% -$1.08M 0.17% 164
2014
Q3
$25.3M Buy
1,767,504
+400,693
+29% +$5.78M 0.15% 173
2014
Q2
$21.9M Sell
1,366,811
-2,027
-0.1% -$30.6K 0.13% 191
2014
Q1
$24.7M Buy
1,368,838
+215,268
+19% +$3.99M 0.15% 189
2013
Q4
$22.6M Buy
+1,153,570
New +$16.9M 0.13% 194

Other funds holding DVAX

Westfield Capital Management's DVAX Position: Q4 2015 in Review

Westfield Capital Management sold out of Dynavax Technologies (DVAX) in Q4 2015, closing a stake of 888,247 shares — an estimated $21.8M sold.

Westfield Capital Management first reported a position in DVAX in Q4 2013 and held it in 8 quarters. The position peaked at $38M in Q1 2015. 152 funds tracked by Wall St. Rank hold DVAX as of Q4 2015.

  • Westfield Capital Management reported no remaining Dynavax Technologies position as of Q4 2015 after selling out during the quarter.
  • Westfield Capital Management sold 888,247 Dynavax Technologies shares in Q4 2015, an estimated $21.8M.
  • Westfield Capital Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 8 quarters.
  • Westfield Capital Management's Dynavax Technologies position peaked at $38M in Q1 2015.
  • 152 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2015.

Based on Westfield Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.